Drug Shortage Report for TEVA-MOMETASONE

Last updated on 2021-04-15 History
Report ID 134746
Drug Identification Number 02248130
Brand name TEVA-MOMETASONE
Common or Proper name MOMETASONE 0.1% OINT
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 0.1%
Dosage form(s) OINTMENT
Route of administration TOPICAL TOPICAL
Packaging size 15g
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-23
Estimated end date 2021-07-31
Actual end date
Shortage status Actual shortage
Updated date 2021-04-15
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-15 French Compare
v5 2021-04-15 English Compare
v4 2021-04-08 French Compare
v3 2021-04-08 English Compare
v2 2021-02-25 French Compare
v1 2021-02-25 English Compare